Core Viewpoint - Silk Road Vision (300556.SZ) reported a decline in revenue and an increase in net loss for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 393 million yuan, representing a year-on-year decrease of 10.95% [1] - The net loss attributable to shareholders of the listed company was 123 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 133 million yuan [1] - The basic loss per share was 1.01 yuan [1]

Core Viewpoint - Silk Road Vision (300556.SZ) reported a decline in revenue and an increase in net loss for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 393 million yuan, representing a year-on-year decrease of 10.95% [1] - The net loss attributable to shareholders of the listed company was 123 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 133 million yuan [1] - The basic loss per share was 1.01 yuan [1]

| 证券代码：300556 | 证券简称：丝路视觉 | 公告编号：2025-081 | | --- | --- | --- | | 债券代码：123138 | 债券简称：丝路转债 | | 丝路视觉科技股份有限公司 关于不向下修正丝路转债转股价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、截至 2025 年 10 月 24 日，丝路视觉科技股份有限公司（以下简称"公司"） 股票（SZ.300556）已出现连续三十个交易日中至少有十五个交易日的收盘价格 低于当期转股价格的 85%的情形，触发丝路转债（123138）转股价格的向下修正 条件。 2、经公司第五届董事会第九次会议审议，决定本次不向下修正丝路转债转 股价格。同时，自本次董事会审议通过之日起至公司 2025 年年度董事会会议召 开之日，如再次触发丝路转债转股价格向下修正条件，公司亦不提出向下修正方 案。下一触发转股价格修正条件的期间从公司 2025 年年度董事会会议召开之日 后一交易日起重新起算，若再次触发丝路转债转股价格向下修正条件，届时公司 董事会将召开会议决定是否行使丝路转 ...

Group 1 - The company Silk Road Vision (SZ 300556) held its ninth board meeting of the fifth session on October 24, 2025, via telecommunication voting, discussing the proposal for the management system for senior executives' departure [1] - For the first half of 2025, Silk Road Vision's revenue composition was 99.98% from CG business and 0.02% from other businesses [1] - As of the report date, Silk Road Vision's market capitalization was 2.5 billion yuan [1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - The secondary market for biomedicine is experiencing a boom, while the primary market is facing challenges in fundraising [1]

Core Viewpoint - Silk Road Vision (300556.SZ) reported a significant decline in revenue and net profit for Q3 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for Q3 2025 was 117 million yuan, representing a year-on-year decrease of 20.38% [1] - The net profit attributable to shareholders of the listed company was -42.27 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -50.43 million yuan [1]

Group 1 - The core viewpoint of the article highlights the financial performance of Silk Road Vision, indicating a decline in revenue and a significant net loss for the third quarter of 2025 [1] - For the first three quarters of 2025, the company's revenue was approximately 393 million yuan, representing a year-on-year decrease of 10.95% [1] - The net profit attributable to shareholders was a loss of approximately 123 million yuan, with basic earnings per share reflecting a loss of 1.01 yuan [1] Group 2 - As of the report, Silk Road Vision has a market capitalization of 2.5 billion yuan [2] - The article also discusses the broader context of the biopharmaceutical market in China, noting that overseas licensing has generated 80 billion US dollars this year [2] - There is a contrast presented between the hot secondary market for biopharmaceuticals and the cooling fundraising environment in the primary market [2]

丝路视觉科技股份有限公司 董事、高级管理人员离职管理制度 丝路视觉科技股份有限公司 （二）审计委员会成员辞任导致审计委员会成员低于法定最低人数，或者欠 缺会计专业人士； 董事、高级管理人员离职管理制度 （2025 年 10 月制定） 第一章 总则 第一条 为规范丝路视觉科技股份有限公司（以下简称"公司"）董事、高 级管理人员离职管理事宜，确保公司治理稳定性，维护公司和股东的权益，根据 《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司章程指引》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律、法规、规范性文件以及《丝路视觉 科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，并结合公司实 际情况，制定本制度。 第二条 本制度适用于公司董事（含独立董事）及高级管理人员（总裁、执 行副总裁、高级副总裁、副总裁、财务总监和董事会秘书）因任期届满、辞任、 被解除职务等离职情形。 第二章 离职情形与生效条件 第三条 公司董事和高级管理人员可以在任期届满前辞职，董事和高级管理 人员辞职应当向公司提交书面辞职报告，辞职报告中应说明辞 ...

丝路视觉科技股份有限公司 董事、高级管理人员所持本公司股份及其变动管理制度 丝路视觉科技股份有限公司 董事、高级管理人员所持本公司股份及其变动管理制度 （2025年10月制定） 第一章 总 则 第一条 为加强对丝路视觉科技股份有限公司（以下简称"公司"或"本公 司"）董事、高级管理人员所持本公司股份及其变动的管理，进一步明确管理程 序，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司董事和高级管理人员 所持本公司股份及其变动管理规则》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》《深 圳证券交易所上市公司自律监管指引第10号——股份变动管理》《深圳证券交易 所上市公司自律监管指引第18号——股东及董事、高级管理人员减持股份》（以 下简称"《减持指引》"）等相关法律法规、规范性文件及《丝路视觉科技股份 有限公司章程》（以下简称"《公司章程》"）的有关规定，特制订本制度。 第二条 公司董事、高级管理人员所持本公司股份，是指登记在其名下的所 有本公司股份。公司董事、高级管理人员从事融 ...

| 证券代码：300556 | 证券简称：丝路视觉 | 公告编号：2025-078 | | --- | --- | --- | | 债券代码：123138 | 债券简称：丝路转债 | | 丝路视觉科技股份有限公司 丝路视觉科技股份有限公司《2025 年第三季度报告》已于 2025 年 10 月 25 日在符合条件的创业板信息披露网站上披露，请投资者注意查阅。 特此公告。 丝路视觉科技股份有限公司董事会 2025 年 10 月 25 日 2025年第三季度报告披露的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 ...

Financial Performance - Revenue for Q3 2025 was CNY 116,525,230.43, a decrease of 20.38% compared to the same period last year[6] - Net profit attributable to shareholders was CNY -42,272,127.35, representing a 60.75% increase in losses year-over-year[6] - The basic earnings per share for Q3 2025 was CNY -0.35, a decrease of 60.67% compared to the same period last year[6] - Net loss attributable to shareholders increased from ¥216,349,368.19 to ¥122,532,416.26, representing a year-over-year increase of approximately 43.4%[24] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 5,684,064.58, an increase of 102.49%[6] - Operating cash flow turned positive during the reporting period, with a net cash flow of ¥5,684,064.58, an increase of 102.49% compared to the previous year[10] - Cash flow from operating activities improved to ¥5,684,064.58 from a negative ¥228,543,799.08 in the previous period[25] - The company reported a net decrease in cash and cash equivalents of ¥278,908,397.76, an improvement of 16.00% year-over-year[11] - The company reported a net decrease in cash and cash equivalents of -$278.91 million, compared to -$332.03 million in the previous period, indicating a slight improvement in cash management[26] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,521,652,208.88, down 15.57% from the previous year[6] - Total current assets decreased from 1,400,316,387.61 to 1,192,475,849.53, a decline of approximately 14.87%[17] - Total liabilities decreased from 1,802,221,909.80 to 1,521,652,208.88, a reduction of about 15.6%[19] - Total liabilities decreased from ¥1,218,798,246.18 to ¥1,062,309,879.86, a reduction of about 12.8%[20] - The company’s total assets decreased from ¥1,802,221,909.80 to ¥1,521,652,208.88, a decline of approximately 15.6%[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 21,917[13] - The largest shareholder, Li Mengdi, holds 13.53% of shares, amounting to 16,451,749 shares, with 7,250,000 shares pledged[13] - The total number of restricted shares at the end of the period is 14,555,162, down from 16,550,768[15] - The company has no significant changes in the top 10 shareholders participating in margin financing[14] - The company has not disclosed any related party transactions among the major shareholders[13] Expenses - Research and development expenses for the year-to-date were CNY 39,140,365.74, a decrease of 17.21% compared to the same period last year[9] - The company reported a significant reduction in management expenses, down 12.68% year-over-year to CNY 67,311,650.19[9] - Total operating costs increased from ¥664,547,770.27 to ¥527,833,886.28, a decrease of about 20.6% year-over-year[23] Investment Activities - Cash inflow from investment activities reached ¥2,414,435,932.07, reflecting a 246.46% increase year-over-year, primarily due to the recovery of principal from bank and brokerage financial products[10] - Cash outflow for investment activities was ¥2,622,347,132.98, up 224.11% from the previous year, mainly due to increased payments for bank and brokerage financial products[10] - The company’s cash inflow from investment activities was significantly negative, highlighting challenges in generating returns from investments[26] Other Financial Metrics - The weighted average return on equity was -8.63%, a decrease of 5.08% compared to the previous year[6] - The company reported a significant loss in retained earnings, amounting to -¥170,285,364.96, reflecting a 256.60% decline due to losses incurred during the reporting period[11] - Basic and diluted earnings per share were both reported at -1.01, compared to -1.78 in the previous period[24] - The company’s cash flow from operating activities increased by approximately 868.5% year-over-year, indicating a significant improvement in operational efficiency[25] Audit Status - The third quarter financial report was unaudited, which may affect the reliability of the reported figures[27]